文献速递心脏核医学

门控心肌灌注SPECT评估心脏再同步治疗患者的舒张期失同步

Diastolic dyssynchrony assessment by gated myocardial perfusion-SPECT in subjects who underwent cardiac resynchronization therapy.
PubMed 文献 · J Nucl Cardiol · 2019-08-13

本回顾性分析纳入10个心脏中心的160例接受心脏再同步治疗(CRT)的患者,用门控心肌灌注SPECT(GMP-SPECT)在基线和6个月随访时评估左室舒张期失同步(LVDD)。结果显示CRT后舒张期失同步标准差从53.53°±20.85降至40.44°±26.1283(P<0.001),但基线LVDD与临床结局改善无关。

要点

  • CRT后6个月舒张期失同步标准差较基线显著降低(P<0.001)。
  • 基线LVDD与随访时心脏功能相关,但与临床结局改善无关。
  • NYHA分级改善105例(65.6%),LVEF改善74例(46.3%)。

核心结论

  • CRT在6个月随访时改善收缩期和舒张期失同步数值。
  • 基线LVDD与随访时心脏功能相关,但与总体临床结局改善无关。

研究设计与样本

  • 事后分析,纳入10个心脏中心160例接受CRT的患者。
  • 用GMP-SPECT在基线和CRT术后评估左室舒张期失同步。
  • CRT按现行指南执行,随访6个月。

主要发现

  • NYHA分级改善105例(65.6%),LVEF改善74例(46.3%)。
  • ESV降低86例(53.8%),Minnesota评分改善85例(53.1%)。
  • 基线舒张期标准差53.53°±20.85,随访40.44°±26.1283(P<0.001)。
  • LVDD与随访时临床结局改善无关联。

关键数值与推荐

  • LVDD定义为舒张期相位标准差≥40±14°。
  • 结局定义:NYHA分级改善≥1级、LVEF改善5%、ESV降低15%、Minnesota问卷改善5分。

临床怎么用

  • GMP-SPECT可评估CRT患者的舒张期失同步并随访其变化。
  • 基线LVDD不宜单独用于预测CRT后临床结局改善。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Left ventricular diastolic dyssynchrony (LVDD) can be assessed by gated myocardial perfusion single-photon emission computed tomography (GMP-SPECT). LVDD is an area of interest in subjects who underwent cardiac resynchronization therapy (CRT). The aim of this post hoc analysis was to assess the role of LVDD in subjects with CRT who were followed up at 6-month period. MATERIAL & METHODS: Left ventricular diastolic dyssynchrony was assessed by GMP-SPECT at baseline and after CRT procedure in 160 subjects from 10 different cardiological centers. CRT procedure was performed as per current guidelines. Outcomes were defined as improvement in ≥1 New York Heart Association (NYHA) class, left ventricular ejection fraction (LVEF) by 5%, and reduction in end-systolic volume (ESV) by 15% and 5% points in Minnesota Living with Heart Failure Questionnaire. LVDD was defined as diastolic phase standard deviation ≥40 ± 14°. RESULTS: Improvement in NYHA functional class occurred in 105 (65.6%), LVEF in 74 (46.3%), decrease in ESV in 86 (53.8%), and Minnesota score in 85 (53.1%) cases. Baseline LV diastolic standard deviation was 53.53° ± 20.85 and at follow-up 40.44° ± 26.1283; (P < 0.001). LVDD was not associated with improvement in clinical outcomes at follow-up. CONCLUSION: CRT improves both systolic and diastolic dyssynchrony values at 6-month follow-up. LVDD at baseline is correlated with cardiac functionality at follow-up, but not with overall favorable clinical outcomes.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Alexanderson-Rosas E, Espinola-Zavaleta N, Garcia EV, et al. Diastolic dyssynchrony assessment by gated myocardial perfusion-SPECT in subjects who underwent cardiac resynchronization therapy. J Nucl Cardiol. 2019. PMID: 31410734. doi:10.1007/s12350-019-01845-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。